Please Wait...

In The News

A wide variety of online and print media sources throughout the world have covered Bioclinica.

In The News

January 16, 2018

Kevin Bishop, who heads up Bioclinica Randomization & Trial Supply Management (RTSM) and leads a team that developed the solution, is featured in the 25th Anniversary special edition of CenterWatch Monthly for Innovations, published January 2018. Kevin describes how Bioclinica is reducing risk to the clinical supply chain through advanced optimization techniques.

November 6, 2017

In a Company statement picked up by the Journal of Clinical Studies, Bioclinica President and CEO John Hubbard says, “Combining the MDDX technology suite with Bioclinica, including advanced cloud research image management and services, is a perfect match, especially for sponsors who want the assurance that the critical medical imaging component of a clinical trial is managed efficiently, accurately, and reliably, regardless of where the trial is held in the world.“

Applied Clinical Trials covers the news of Bioclinica’s acquisition of Silicon Valley-based MDDX Research & Informatics. With the acquisition, Bioclinica adds advanced cloud research image management and submission technologies to our extensive suite of medical imaging and eHealth solutions. As the backbone of Bioclinica's SMART solution, the technology is a major leap forward in the image submission process for clinical research sites.

Contract Pharma reports Breaking News of Bioclinica’s acquisition of MDDX, a Silicon-Valley based technology disruptor in life sciences.

As reported in Clinical Informatics News, the MDDX platform is FDA 21 CFR Part 11 compliant. Powered by artificial intelligence and machine-learning technologies, the technology integrates more than 1,500 screening and de-identification rules to detect image issues and automatically de-identify any standard image type. An online hosting environment offers real-time access to imaging data along with audit trail transparency.

In this Outsourcing Pharma article, MDDX founder Dan Gebow and Bioclinica President Medical Imaging & eHealth Solutions David Herron tell Melissa Fassbender about the acquisition and how it gives sponsors and CROs access to medical imaging technology, which can help determine patient clinical trial eligibility in under an hour.

More on the MDDX acquisition and what it brings to clinical research sites and the life sciences industry in Fierce Biotech.

August 4, 2017

July 20, 2017

May 9, 2017

May 1, 2017

April 3, 2017

February 22, 2017

January 31, 2017

October 3, 2016

August 12, 2016

August 9, 2016

August 1, 2016

July 26, 2016

July 25, 2016

June 27, 2016

May 26, 2016

April 20, 2016

April 19, 2016

April 4, 2016


Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

A great resource for Alzheimers's research teams.
bioclinica (18 hours ago)
RT @bioclinica: #Pharmacovigilance: Get up-to-speed on latest ind. trends & best practices + hear how others R meeting today's most pressin…
bioclinica (19 hours ago)
RT @Xtalks: Trends in #Pharmacovigilance – Market Research and Future Impact This webinar will discuss an overview of key findings within r…
bioclinica (19 hours ago)
RT @IntClinTrials: Patient loss and can reduced by introducing new methods during the follow-up period. Martin Collyer at @bioclinica tells…
bioclinica (19 hours ago)
@bioclinica experts talk candidly about #Alzheimer's research & where improvements can be made. Joyce Suhy, Marieke…
bioclinica (19 hours ago)
RT @ACROhealth: @MaryWolleyRA Mary Woolley @ResearchAmerica: 80% have heard of #clinicaltrials. 75% think trial participation is as importa…
bioclinica (1 week ago)

Latest Blogs:

Latin America: Benefit from the Right Partner
Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen